RM
RP Management Portfolio holdings
AUM
$139M
This Quarter Return
+14.72%
1 Year Return
-37.98%
3 Year Return
+207.23%
5 Year Return
+1,005.94%
10 Year Return
–
AUM
$299M
AUM Growth
+$299M
(-53%)
Cap. Flow
-$372M
Cap. Flow
% of AUM
-124.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$372M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $181M | 55.51% |
2,111,111
| – | – |
|
|
EPZM
2
DELISTED
Epizyme, Inc
EPZM
| $99.6M | 30.54% |
9,166,667
| – | – |
|
3
Cytokinetics
CYTK
$4.23B
| $18.2M | 5.58% |
875,656
| – | – |
|
|
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $26K | 0.01% |
129,517
| – | – |
|
|
IMMU
5
DELISTED
Immunomedics Inc
IMMU
| – | – |
-4,373,178
| Closed | -$372M |
|